NEOLEUKIN THERAPEUTICS INC - COM (NLTX)

CUSIP: 64049K104

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / COM
Total 13F shares
18,711,231
Share change
-2,082,428
Total reported value
$11,975,000
Price per share
$0.64
Number of holders
44
Value change
-$2,153,724
Number of buys
10
Number of sells
26

Quarterly Holders Quick Answers

What is CUSIP 64049K104?
CUSIP 64049K104 identifies NLTX - NEOLEUKIN THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NEOLEUKIN THERAPEUTICS INC - COM (NLTX) as of Q3 2022

As of 30 Sep 2022, NEOLEUKIN THERAPEUTICS INC - COM (NLTX) was held by 44 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,711,231 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, Redmile Group, LLC, Point72 Asset Management, L.P., MILLENNIUM MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, BlackRock Inc., MORGAN STANLEY, Opaleye Management Inc., and BARCLAYS PLC. This page lists 44 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.